- Anatomisches Institut/Neuroanatomie
- Multiple Sclerosis
- B-cells
- biomarkers
Tacke S, Braune S, Rovituso DM, Ziemssen T, Lehmann PV, Dikow H, Bergmann A, Kuerten S (2021) B-cell activity predicts response to glatiramer acetate and interferon in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm
Kuerten S, Lanz TV, Lingampalli N, Lahey LJ, Kleinschnitz C, Mäurer M, Schroeter M, Braune S, Ziemssen T, Ho PP, Robinson WH, Steinman L (2020) Autoantibodies against CNS antigens in a subset of B cell-dominant multiple sclerosis patients. Proc Natl Acad Sci U S A 117(35):21512-21518
Wunsch M, Jabari S, Voussen B, Enders M, Srinivasan S, Cossais F, Wedel T, Boettner M, Schwarz A, Weyer L, Göcer O, Schroeter M, Maeurer M, Woenckhaus M, Pollok K, Radbruch H, Klotz L, Scholz C, Nickel J, Friebe A, Addicks K, Ergün S, Lehmann PV, Kuerten S (2017) The enteric nervous system is a potential autoimmune target in multiple sclerosis. Acta Neuropathol 134(2):281-295
Schampel A, Volovitch O, Koeniger T, Scholz C, Jörg S, Linker RA, Wischmeyer E, Wunsch M, Hell JW, Ergün S, Kuerten S (2017) Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis. Proc Natl Acad Sci U S A, 114(16):E3295-E3304